Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction between rat serum phosphorylcholine binding protein and platelet activating factor.

E Randell1, S Mookerjea, A Nagpurkar

  • 1Department of Biochemistry, Memorial University of Newfoundland St. John's, Canada.

Biochemical and Biophysical Research Communications
|March 16, 1990
PubMed
Summary

Rat serum phosphorylcholine binding protein (PCBP) binds to platelet-activating factor (PAF) in a calcium-dependent manner. This specific binding interaction, mediated by the phosphorylcholine site, may explain PCBP

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a core outcome set for the evaluation of interventions to enhance trial participation decisions on behalf of adults who lack capacity to consent: a mixed methods study (COnSiDER Study).

Trials·2021
Same author

Who's challenging who training for staff empathy towards adults with challenging behaviour: cluster randomised controlled trial.

Journal of intellectual disability research : JIDR·2018
Same author

Tuberculosis in the Circumpolar Region, 2006-2012.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2018
Same author

Metabolomic analysis of human plasma reveals that arginine is depleted in knee osteoarthritis patients.

Osteoarthritis and cartilage·2015
Same author

High salt intake does not exacerbate murine autoimmune thyroiditis.

Clinical and experimental immunology·2014
Same author

Cervical spine loading characteristics in a cadaveric C5 corpectomy model using a static and dynamic plate.

Journal of spinal disorders & techniques·2004

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation and thrombosis.
  • Phosphorylcholine binding protein (PCBP) is a serum protein known to bind phosphorylcholine-containing molecules.
  • The interaction between PCBP and PAF has not been fully elucidated, particularly regarding its molecular basis and functional implications.

Purpose of the Study:

  • To investigate the binding characteristics between rat serum PCBP and PAF.
  • To determine the role of calcium ions and the phosphorylcholine binding site in PCBP-PAF complex formation.
  • To explore the specificity of PCBP binding to PAF and its potential implications for PAF-induced platelet aggregation.

Main Methods:

  • High-Performance Liquid Chromatography (HPLC) coupled with gel filtration chromatography was employed.

Related Experiment Videos

  • Radioactive [3H]-labeled PAF was used to detect and quantify binding to PCBP.
  • Experiments were conducted in the presence and absence of calcium ions and phosphorylcholine.

    • Main Results:

    • PCBP was shown to bind [3H]-PAF, with the majority of bound PAF eluting with a higher molecular weight PCBP species (possibly aggregated PCBP).
    • A smaller fraction of [3H]-PAF co-eluted with the monomeric form of PCBP.
    • PCBP-PAF complex formation was dependent on calcium ions and was inhibited by phosphorylcholine, indicating the involvement of the PCBP's phosphorylcholine binding site.

    Conclusions:

    • Rat serum PCBP directly binds to PAF, forming complexes with both aggregated and monomeric forms of the protein.
    • The binding is specific, calcium-dependent, and mediated through the phosphorylcholine binding site of PCBP.
    • This specific interaction provides a molecular basis for the inhibitory effect of PCBP on PAF-induced platelet aggregation.